TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES WITH EPRATUZUMAB
摘要
The invention relates to the treatment of autoimmune or inflammatory disorders with antibodies to CD22. In particular, the invention relates to the treatment of autoimmune or inflammatory disorders with epratuzumab with a new dosing regimen. More particularly, the invention relates to the treatment of SLE.
申请公布号
WO2011032633(A1)
申请公布日期
2011.03.24
申请号
WO2010EP05225
申请日期
2010.08.26
申请人
UCB PHARMA, S.A.;NOVOTNEY-BARRY, ANNA-MARIE;HULHOVEN, REGINALD;PARKER, GERALD, L.;HOSKIN, VIOLET, A.;UCB, INC.
发明人
NOVOTNEY-BARRY, ANNA-MARIE;HULHOVEN, REGINALD;PARKER, GERALD, L.;HOSKIN, VIOLET, A.
